The estimated Net Worth of Sarah Boyce is at least $11.6 Million dollars as of 6 August 2024. Ms Boyce owns over 28,000 units of Avidity Biosciences stock worth over $9,447,563 and over the last 9 years she sold RNA stock worth over $1,349,420. In addition, she makes $823,093 as Pres and CEO & Director at Avidity Biosciences.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Ms Boyce RNA stock SEC Form 4 insiders trading
Ms has made over 19 trades of the Avidity Biosciences stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 28,000 units of RNA stock worth $34,720 on 6 August 2024.
The largest trade she's ever made was exercising 300,000 units of Avidity Biosciences stock on 12 June 2024 worth over $372,000. On average, Ms trades about 20,500 units every 80 days since 2016. As of 6 August 2024 she still owns at least 233,043 units of Avidity Biosciences stock.
You can see the complete history of Ms Boyce stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Sarah Boyce biography
Sarah Boyce is the Pres, CEO & Director at Avidity Biosciences.
What is the salary of Ms Boyce?
As the Pres and CEO & Director of Avidity Biosciences, the total compensation of Ms Boyce at Avidity Biosciences is $823,093. There are no executives at Avidity Biosciences getting paid more.
How old is Ms Boyce?
Ms Boyce is 49, she's been the Pres and CEO & Director of Avidity Biosciences since . There are 6 older and no younger executives at Avidity Biosciences. The oldest executive at Avidity Biosciences, Inc. is Dr. Frank McCormick Ph.D., 71, who is the Scientific Founder & Member of Scientific Advisory Board.
What's Ms Boyce's mailing address?
Sarah's mailing address filed with the SEC is C/O AVIDITY BIOSCIENCES, INC., 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA, 92121.
Insiders trading at Avidity Biosciences
Over the last 4 years, insiders at Avidity Biosciences have traded over $8,545,325 worth of Avidity Biosciences stock and bought 2,050,000 units worth $36,900,000 . The most active insiders traders include Investments, Lpwong Roderic..., Lilly & Co Eli, and Asset Management, Lp Chen B.... On average, Avidity Biosciences executives and independent directors trade stock every 34 days with the average trade being worth of $3,142,336. The most recent stock trade was executed by Arthur A Levin on 19 August 2024, trading 5,000 units of RNA stock currently worth $6,200.
What does Avidity Biosciences do?
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
What does Avidity Biosciences's logo look like?
Complete history of Ms Boyce stock trades at Ionis Pharmaceuticals Inc, Ligand Pharmaceuticals, Akcea Therapeutics Inc, Avidity Biosciences, and Berkeley Lights
Avidity Biosciences executives and stock owners
Avidity Biosciences executives and other stock owners filed with the SEC include:
-
Sarah Boyce,
Pres, CEO & Director -
Michael F. MacLean,
Chief Financial Officer -
Dr. Troy Edward Wilson J.D., Ph.D.,
Co-Founder & Chairman -
Teresa McCarthy,
Chief HR Officer -
Dr. John W. Wallen III,
VP of Intellectual Property, Gen. Counsel & Sec. -
Kathleen Gallagher,
Sr. VP of Corp. Communications & Investor Relations -
Dr. Arthur A. Levin Ph.D.,
Chief Scientific Officer -
Dr. W. Michael Flanagan Ph.D.,
Chief Technical Officer -
Dr. Frank McCormick Ph.D.,
Scientific Founder & Member of Scientific Advisory Board -
Prof. Mark E. Davis,
Scientific Founder, Member of Scientific Advisory Board and Member of Board of Mang.s -
Arthur A Levin,
Director -
John B Moriarty,
Chief Legal Officer -
Michael F Mac Lean,
Chief Financial Officer -
Jae B. Kim,
Chief Medical Officer -
Troy Edward Wilson,
Director -
Asset Management, Lp Chen B...,
-
Lilly & Co Eli,
-
Tamar Thompson,
Director -
Jean Jinsun Kim,
Director -
Joseph Baroldi,
Chief Operating Officer -
Sarah Boyce,
President and CEO -
Noreen Henig,
Director -
Edward M. Md Kaye,
Director -
Carsten Boess,
Director -
Roderick Wong,
Director -
Investments, Lpwong Roderic...,
MP and CIO -
Eric Mosbrooker,
Director -
Teresa Mc Carthy,
Chief Human Resources Officer -
W. Michael Flanagan,
CSTO -
Simona Skerjanec,